Drawing for PRYVECTO

USPTO serial 85924180

PRYVECTO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
VOHRA, SANJEEV KUMAR
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRYVECTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

MAURY M. TEPPER, III TEPPER & EYSTER, PLLC3724 BENSON DRRALEIGH, NC 27609-7321UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthmaACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 19, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 19, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 11, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2016EX5GSOU EXTENSION 5 GRANTED
May 5, 2016EXT5SOU EXTENSION 5 FILED
May 5, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 3, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2015EX4GSOU EXTENSION 4 GRANTED
Oct 29, 2015EXT4SOU EXTENSION 4 FILED
Oct 29, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2015EX3GSOU EXTENSION 3 GRANTED
May 8, 2015EXT3SOU EXTENSION 3 FILED
May 8, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 16, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 15, 2014EX2GSOU EXTENSION 2 GRANTED
Dec 15, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 10, 2014EXT2SOU EXTENSION 2 FILED
Nov 10, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 26, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2014EX1GSOU EXTENSION 1 GRANTED
Apr 24, 2014EXT1SOU EXTENSION 1 FILED
Apr 24, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 17, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2013DOCKASSIGNED TO EXAMINER
May 13, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2013NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance